Salter Malcolm 4
4 · C4 Therapeutics, Inc. · Filed Jun 16, 2023
Insider Transaction Report
Form 4
Salter Malcolm
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-15+26,000→ 26,000 totalExercise: $3.61Exp: 2033-06-14→ Common Stock (26,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2024 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date.